LOXL1 and glioma: As shown in Figure 5F–H, cell proliferation, migration, invasion and VM in glioma (henceforth, ‘malignant cell behaviour’) were greatly inhibited in the LOXL1‐AS1(−)+pre‐miR‐374b‐5p group compared with those of the NCs.